NovaBay Pharmaceuticals, Inc. (NBY)
1.47
+0.26
(+21.49%)
USD |
NYAM |
Mar 16, 16:00
1.46
-0.01
(-0.68%)
After-Hours: 17:26
NovaBay Pharmaceuticals EPS Diluted (Quarterly) : -1.100 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.2596 |
| cbdMD, Inc. | -0.036 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.333M |
| Revenue (Quarterly) | 0.521M |
| Total Expenses (Quarterly) | 1.854M |
| Enterprise Value | 34.59M |
| Gross Profit Margin (Quarterly) | 8.06% |
| Profit Margin (Quarterly) | -255.9% |
| Earnings Yield | -183.0% |
| Normalized Earnings Yield | -177.63 |